CA
NZ
UK
AU
IND
US
…
Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers Invisalign comprehensive package to treat adults and teens malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients between the ages of six and ten years with a mixture of primary/baby and permanent teeth. This segment also provides Invisalign express, Invisalign lite, and Invisalign moderate; Invisalign Go, Invisalign Go express, and Invisalign Go Plus; retention products, Invisalign training, adjusting tools used by dental professionals during treatment, ancillary Invisalign accessory products, and other oral health products; Invisalign Professional Whitening system; Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions. Its Imaging Systems and CAD/CAM Services segment offers iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; exocad, a computer-aided design and computer-aided manufacturing software; orthodontist software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers; and restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons. This segment also offers Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; Align Oral Health Suite, a digital interface for dental consultations; iTero TimeLapse technology for doctors or practitioners to compare a patient's historic 3D scans to the present-day scan; and subscription software, disposables, rents scanners, and pay per scan services. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Align Technology makes Invisalign clear aligners, iTero intraoral scanners and digital treatment‑planning software for dental professionals globally. Long‑term growth may be supported by rising adoption of clear‑aligner therapy, wider iTero scanner penetration that enables digital workflows, and geographic expansion; investors may value the company's leading market position and integrated platform that can generate recurring procedure demand.
Principal risks include intensifying competition from other aligner makers and direct‑to‑consumer models, pricing and execution pressure in manufacturing and supply chains, regulatory or legal challenges, and sensitivity to elective dental spending.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 585.29M | 608.96M | 641.20M | 599.06M | 1012.42M |
| Net income | 410.35M | 421.36M | 445.05M | 361.57M | 772.02M |
| Selling general administrative | 1755.79M | 1578.19M | 1710.94M | 1674.47M | 1708.64M |
| Selling and marketing expenses | - | 185.00M | - | - | - |
| Gross profit | 2756.90M | 2799.16M | 2706.86M | 2633.78M | 2935.36M |
| Reconciled depreciation | 237.44M | 145.03M | 142.37M | 125.79M | 108.73M |
| Ebit | 585.29M | 671.76M | 643.34M | 642.60M | 867.67M |
| Ebitda | 765.87M | 816.80M | 643.34M | 665.50M | 976.40M |
| Depreciation and amortization | 180.59M | 145.03M | -13.99M | 22.91M | 108.73M |
| Non operating income net other | - | - | - | - | 36.02M |
| Operating income | 616.22M | 607.63M | 643.34M | 642.60M | 976.40M |
| Other operating expenses | 3418.75M | 3391.38M | 3205.61M | 3080.59M | 2976.18M |
| Interest expense | - | - | 2.13M | 5.37M | 36.02M |
| Tax provision | 174.94M | 187.60M | 220.83M | 237.48M | 240.40M |
| Interest income | 16.05M | 20.22M | 15.04M | 5.37M | 3.10M |
| Net interest income | 16.05M | 20.22M | 15.04M | 5.37M | 3.10M |
| Income tax expense | 174.94M | 187.60M | 196.15M | 237.48M | 240.40M |
| Total revenue | 4034.96M | 3999.01M | 3862.26M | 3734.64M | 3952.58M |
| Total operating expenses | 2140.68M | 2191.53M | 2050.21M | 1979.73M | 1958.95M |
| Cost of revenue | 1278.07M | 1199.85M | 1155.40M | 1100.86M | 1017.23M |
| Total other income expense net | -30.93M | 1.33M | -2.13M | -43.54M | 36.02M |
| Net income from continuing ops | 410.35M | 421.36M | 362.81M | 361.57M | 772.02M |
| Net income applicable to common shares | - | - | - | 361.57M | 772.02M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 6233.69M | 6214.60M | 6083.88M | 5947.95M | 5942.11M |
| Intangible assets | 93.93M | 103.49M | 82.12M | 95.72M | 109.71M |
| Other current assets | 137.74M | 164.55M | 273.55M | 226.37M | 125.09M |
| Total liab | 2184.55M | 2362.61M | 2453.39M | 2346.59M | 2319.40M |
| Total stockholder equity | 4049.15M | 3851.99M | 3630.49M | 3601.36M | 3622.71M |
| Deferred long term liab | - | - | - | 27.40M | 31.10M |
| Other current liab | 504.81M | 470.66M | 496.13M | 427.80M | 584.60M |
| Common stock | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M |
| Capital stock | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M |
| Retained earnings | 2464.16M | 2483.77M | 2447.17M | 2566.69M | 2619.37M |
| Other liab | - | - | - | 320.37M | 292.67M |
| Good will | 491.83M | 442.63M | 419.53M | 407.55M | 418.55M |
| Other assets | - | - | - | 1627.57M | 1591.28M |
| Cash | 1078.99M | 1043.89M | 937.44M | 942.05M | 1099.37M |
| Total current liabilities | 1920.02M | 2038.03M | 2066.61M | 1925.89M | 1924.07M |
| Current deferred revenue | 1261.82M | 1331.15M | 1427.71M | 1343.64M | 1152.87M |
| Net debt | -964.54M | -924.61M | -840.47M | -815.14M | -996.71M |
| Short term debt | 31.94M | 31.06M | 29.65M | 26.57M | 22.72M |
| Short long term debt total | 114.45M | 119.28M | 96.97M | 126.91M | 102.66M |
| Other stockholder equity | 1509.60M | 1362.23M | 1162.14M | 1044.95M | 999.01M |
| Property plant equipment | - | - | - | 1350.73M | 1203.18M |
| Total current assets | 2616.56M | 2492.44M | 2446.62M | 2424.39M | 2494.07M |
| Long term investments | - | 0.00M | 8.02M | 41.98M | 125.32M |
| Net tangible assets | - | - | - | 3098.09M | 3094.46M |
| Short term investments | 15.92M | 0.00M | 35.30M | 57.53M | 71.97M |
| Net receivables | 1157.58M | 1029.71M | 903.42M | 859.68M | 897.20M |
| Inventory | 226.34M | 254.29M | 296.90M | 338.75M | 230.23M |
| Accounts payable | 121.45M | 108.69M | 113.12M | 127.87M | 163.89M |
| Accumulated other comprehensive income | 75.39M | 5.98M | 21.17M | -10.28M | 4.33M |
| Common stock total equity | - | - | - | - | 0.01M |
| Retained earnings total equity | - | - | - | - | 2619.37M |
| Non currrent assets other | 278.05M | 234.16M | 128.68M | 55.83M | 57.51M |
| Non current assets total | 3617.13M | 3722.16M | 3637.26M | 3523.56M | 3448.03M |
| Capital lease obligations | 114.45M | 119.28M | 126.62M | 100.33M | 102.66M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | 0.00M | -254.91M | -238.43M | -213.32M | -563.43M |
| Change to liabilities | - | - | - | 205.36M | 653.38M |
| Total cashflows from investing activities | -112.44M | -254.91M | -195.94M | -213.32M | -563.43M |
| Total cash from financing activities | -464.58M | -355.72M | -598.34M | -501.69M | -458.33M |
| Change to operating activities | - | - | - | -187.46M | 33.92M |
| Net income | 410.35M | 421.36M | 445.05M | 361.57M | 772.02M |
| Change in cash | 51.22M | 106.44M | -3.84M | -157.78M | 138.66M |
| Begin period cash flow | 1044.96M | 938.52M | 942.36M | 1100.14M | 961.47M |
| End period cash flow | 1096.19M | 1044.96M | 938.52M | 942.36M | 1100.14M |
| Total cash from operating activities | 593.22M | 738.23M | 785.78M | 568.73M | 1172.54M |
| Issuance of capital stock | 21.75M | 25.28M | 26.59M | 26.15M | 25.62M |
| Depreciation | 237.44M | 145.03M | 142.40M | 125.79M | 108.73M |
| Other cashflows from investing activities | -112.44M | 0.23M | 0.28M | -2.21M | -563.43M |
| Change to inventory | 0.81M | 25.05M | 30.17M | -130.10M | -112.45M |
| Change to account receivables | -139.91M | -153.49M | -104.61M | 21.55M | -262.07M |
| Sale purchase of stock | -465.94M | -352.88M | -592.36M | -435.04M | -375.04M |
| Other cashflows from financing activities | -20.39M | -28.12M | -32.58M | -92.80M | -108.92M |
| Change to netincome | - | - | - | 165.68M | 1172.54M |
| Capital expenditures | 102.44M | 115.58M | 177.72M | 291.90M | 401.10M |
| Change receivables | - | - | - | - | -262.07M |
| Cash flows other operating | - | - | - | - | -141.22M |
| Cash and cash equivalents changes | - | - | - | - | 150.78M |
| Change in working capital | -356.01M | -72.43M | -7.89M | -84.31M | 154.24M |
| Stock based compensation | 185.87M | 173.70M | 154.03M | 133.37M | 114.34M |
| Other non cash items | 268.37M | 44.81M | 70.83M | 71.81M | 7.77M |
| Free cash flow | 490.78M | 622.65M | 608.06M | 276.83M | 771.45M |
Sector: Healthcare Industry: Medical Instruments & Supplies
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| ALGN Align Technology Inc |
1.67 1.10% |
153.62 | 34.61 | 17.04 | 3.46 | 3.39 | 3.16 | 15.49 |
| ISRG Intuitive Surgical Inc |
-1.70 0.38% |
444.18 | 43.30 | 31.35 | 12.25 | 7.35 | 11.63 | 30.22 |
| ESLOF EssilorLuxottica Société anonyme |
-3.50 1.72% |
200.50 | 44.84 | 27.62 | 4.07 | 2.49 | 3.71 | 16.04 |
| ESLOY Essilor International SA |
-2.13 2.10% |
99.11 | 41.68 | 27.25 | 3.94 | 2.45 | 3.71 | 16.04 |
| BDX Becton Dickinson and Company |
0.13 0.07% |
195.16 | 31.62 | 13.76 | 2.25 | 2.04 | 2.93 | 13.40 |
Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers Invisalign comprehensive package to treat adults and teens malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients between the ages of six and ten years with a mixture of primary/baby and permanent teeth. This segment also provides Invisalign express, Invisalign lite, and Invisalign moderate; Invisalign Go, Invisalign Go express, and Invisalign Go Plus; retention products, Invisalign training, adjusting tools used by dental professionals during treatment, ancillary Invisalign accessory products, and other oral health products; Invisalign Professional Whitening system; Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions. Its Imaging Systems and CAD/CAM Services segment offers iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; exocad, a computer-aided design and computer-aided manufacturing software; orthodontist software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers; and restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons. This segment also offers Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; Align Oral Health Suite, a digital interface for dental consultations; iTero TimeLapse technology for doctors or practitioners to compare a patient's historic 3D scans to the present-day scan; and subscription software, disposables, rents scanners, and pay per scan services. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.
410 North Scottsdale Road, Tempe, AZ, United States, 85288
602 742 2000
20290
| Name | Title | Year Born |
|---|---|---|
| Mr. Joseph M. Hogan | Pres, CEO & Director | 1957 |
| Mr. John F. Morici | CFO & Exec. VP of Global Fin. | 1967 |
| Mr. Emory M. Wright | Exec. VP of Global Operations | 1970 |
| Ms. Julie Ann Coletti | Exec. VP and Chief Legal & Regulatory Officer | 1969 |
| Mr. Stuart Hockridge | Exec. VP of Global HR | 1972 |
| Mr. Zelko Relic | Exec. VP & CTO | 1965 |
| Ms. Shirley Stacy | VP of Corp. Communications & Investor Relations | NA |
| Mr. Vamsi Mohan-Raj Pudipeddi | Exec. VP, Chief Product & Marketing Officer and MD of Asia Pacific | 1972 |
| Mr. Simon Beard | MD for Americas Region & Exec. VP | 1967 |
| Ms. Jennifer Olson-Wilk | Exec. VP of Customer Success | 1978 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
+0.02%
Communication Services
-0.63%
Consumer Cyclical
-0.11%
Consumer Defensive
-0.45%
Energy
+0.39%
Financial Services
-0.10%
Financials
-0.81%
Healthcare
+1.03%
Industrials
+0.32%
Real Estate
-0.31%
Technology
+0.59%
Utilities
-0.18%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
Please wait processing your request...